Covid Antibody
-
{
- All
- News
- Videos
-
Congo Reports Over 130 Suspected Ebola Deaths
Kinshasa, May 19 (IANS) Around 131 suspected deaths and 513 suspected cases have been reported in the latest Ebola outbreak in the Democratic Republic of the Congo (DRC), DRC Health Minister Roger Kamba said Tuesday.
-
Are Hantavirus Tests Like Covid Tests? Doctors Explain Key Differences
Unlike Covid-19, hantavirus cannot be detected using rapid antigen kits. Doctors explain why diagnosis depends on specialised blood tests, PCR analysis and clinical suspicion, especially during severe respiratory illness outbreaks.
-
Are Nasal Vaccines The Future? Scientists Explain The Rise of Needle-Free Immunisation
Nasal vaccines represent a promising shift in how we prevent infectious diseases. By building immunity at the body's first line of defence, they could stop infections before they begin, reduce transmission, and complement traditional vaccines.
-
Antibody That Can Counter All Known Covid Variants Found
Researchers have discovered an antibody that could counter all known variants of the coronavirus that causes COVID-19 and also distantly related ones that infect other animals.
-
'Eris' Covid Variant Can Escape Immunity Better Than Other Strains: Lancet Study
The EG.5.1 variant of SARS-CoV-2 can escape neutralising antibodies better than other currently circulating strains, giving it an advantage in infecting vaccinated or previously infected people, according to a study published in
-
Coronavirus: Everything You Need To Know About The New Covid Variant Arcturus
In this article, we discuss all the latest info about the Arcturus variant, its symptoms, and how you can prevent getting infected.
-
WHO "Strongly" Advises Against Use Of 2 Covid Antibody Treatments: Report
Two COVID-19 antibody treatments are no longer recommended by the World Health Organisation because Omicron and its subvariants have likely rendered them obsolete, according to a revised guideline published in the British Medical Journal.
-
New Omicron Sub-Variants Can Dodge Immunity, May Trigger Wave: Study
Two new sublineages of the Omicron coronavirus variant can dodge antibodies from earlier infection well enough to trigger a new wave.
-
Nearly 60% Of US Population Had Covid By February: Health Body
By February of this year, 58 percent of the US population -- more than 190 million people -- had been infected with Covid, according to an antibody survey by the Centers for Disease Control and Prevention (CDC) published Tuesday.
-
New Indian Covid Vaccine Candidate Can Withstand Even 100 Degrees Celsius
A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.
-
Booster Dose Of Covid Vaccine Needed To Fight Against Omicron: Study
Neutralising antibody levels waned after six months in those who were fully vaccinated against the coronavirus with Covishield, Covaxin and a mix of both with regard to Omicron variant, a study done by the National Institute of Virology indicated.
-
Covid Vaccine-Induced Antibodies Don't Protect Against Omicron, Booster Critical: Study
Antibodies produced by two-doses of mRNA vaccines against the original and early variants of the SARS-CoV-2 virus wane substantially over time, and offer essentially no protection against Omicron, according to a study.
-
Quality Of Antibodies Improves For Months After Covid Vaccination: Study
Antibodies produced by immune cells become steadily more formidable and precisely targeted against the SARS-CoV-2 virus for at least six months after COVID-19 vaccination, according to a study.
-
Exercising After Getting Covid Vaccine Boosts Antibodies: Study
Mild- to moderate-intensity exercise for 90 minutes after getting a flu or COVID-19 vaccine may boost the levels of antibodies in the body, according to a study.
-
Patients With High Covid Risk Least Likely To Get Monoclonal Antibodies: Study
According to new research, people over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs). -- a highly effective treatment for the disease -- both across and within US states.
-
Congo Reports Over 130 Suspected Ebola Deaths
Kinshasa, May 19 (IANS) Around 131 suspected deaths and 513 suspected cases have been reported in the latest Ebola outbreak in the Democratic Republic of the Congo (DRC), DRC Health Minister Roger Kamba said Tuesday.
-
Are Hantavirus Tests Like Covid Tests? Doctors Explain Key Differences
Unlike Covid-19, hantavirus cannot be detected using rapid antigen kits. Doctors explain why diagnosis depends on specialised blood tests, PCR analysis and clinical suspicion, especially during severe respiratory illness outbreaks.
-
Are Nasal Vaccines The Future? Scientists Explain The Rise of Needle-Free Immunisation
Nasal vaccines represent a promising shift in how we prevent infectious diseases. By building immunity at the body's first line of defence, they could stop infections before they begin, reduce transmission, and complement traditional vaccines.
-
Antibody That Can Counter All Known Covid Variants Found
Researchers have discovered an antibody that could counter all known variants of the coronavirus that causes COVID-19 and also distantly related ones that infect other animals.
-
'Eris' Covid Variant Can Escape Immunity Better Than Other Strains: Lancet Study
The EG.5.1 variant of SARS-CoV-2 can escape neutralising antibodies better than other currently circulating strains, giving it an advantage in infecting vaccinated or previously infected people, according to a study published in
-
Coronavirus: Everything You Need To Know About The New Covid Variant Arcturus
In this article, we discuss all the latest info about the Arcturus variant, its symptoms, and how you can prevent getting infected.
-
WHO "Strongly" Advises Against Use Of 2 Covid Antibody Treatments: Report
Two COVID-19 antibody treatments are no longer recommended by the World Health Organisation because Omicron and its subvariants have likely rendered them obsolete, according to a revised guideline published in the British Medical Journal.
-
New Omicron Sub-Variants Can Dodge Immunity, May Trigger Wave: Study
Two new sublineages of the Omicron coronavirus variant can dodge antibodies from earlier infection well enough to trigger a new wave.
-
Nearly 60% Of US Population Had Covid By February: Health Body
By February of this year, 58 percent of the US population -- more than 190 million people -- had been infected with Covid, according to an antibody survey by the Centers for Disease Control and Prevention (CDC) published Tuesday.
-
New Indian Covid Vaccine Candidate Can Withstand Even 100 Degrees Celsius
A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.
-
Booster Dose Of Covid Vaccine Needed To Fight Against Omicron: Study
Neutralising antibody levels waned after six months in those who were fully vaccinated against the coronavirus with Covishield, Covaxin and a mix of both with regard to Omicron variant, a study done by the National Institute of Virology indicated.
-
Covid Vaccine-Induced Antibodies Don't Protect Against Omicron, Booster Critical: Study
Antibodies produced by two-doses of mRNA vaccines against the original and early variants of the SARS-CoV-2 virus wane substantially over time, and offer essentially no protection against Omicron, according to a study.
-
Quality Of Antibodies Improves For Months After Covid Vaccination: Study
Antibodies produced by immune cells become steadily more formidable and precisely targeted against the SARS-CoV-2 virus for at least six months after COVID-19 vaccination, according to a study.
-
Exercising After Getting Covid Vaccine Boosts Antibodies: Study
Mild- to moderate-intensity exercise for 90 minutes after getting a flu or COVID-19 vaccine may boost the levels of antibodies in the body, according to a study.
-
Patients With High Covid Risk Least Likely To Get Monoclonal Antibodies: Study
According to new research, people over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs). -- a highly effective treatment for the disease -- both across and within US states.
